177 related articles for article (PubMed ID: 10971862)
1. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
[TBL] [Abstract][Full Text] [Related]
4. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
[TBL] [Abstract][Full Text] [Related]
9. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
Korba BA; Xie H; Wright KN; Hornbuckle WE; Gerin JL; Tennant BC; Hostetler KY
Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis-b-virus infections: new options for antiviral therapy].
de Man RA; Honkoop P; Janssen HL; Schalm SW
Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1857-61. PubMed ID: 10526598
[TBL] [Abstract][Full Text] [Related]
11. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
12. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
13. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Williams R
Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
Zahm FE; Bonino F; Giuseppetti R; Rapicetta M
Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108
[TBL] [Abstract][Full Text] [Related]
15. Lamivudine therapy of WHV-infected woodchucks.
Mason WS; Cullen J; Moraleda G; Saputelli J; Aldrich CE; Miller DS; Tennant B; Frick L; Averett D; Condreay LD; Jilbert AR
Virology; 1998 May; 245(1):18-32. PubMed ID: 9614864
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis B: interferon alfa first.
Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.
Zhou T; Guo JT; Nunes FA; Molnar-Kimber KL; Wilson JM; Aldrich CE; Saputelli J; Litwin S; Condreay LD; Seeger C; Mason WS
J Virol; 2000 Dec; 74(24):11754-63. PubMed ID: 11090175
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Morrey JD; Korba BE; Sidwell RW
Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
[TBL] [Abstract][Full Text] [Related]
20. Recent progress and new trends in the treatment of hepatitis B.
Alberti A; Brunetto MR; Colombo M; Craxì A
J Med Virol; 2002 Jul; 67(3):458-62. PubMed ID: 12116046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
